PURPOSE: The aim of this study was to construct a prediction model for posthepatectomy liver failure (PHLF), as defined by the International Study Group of Liver Surgery, and evaluate its accuracy in hepatocellular carcinoma (HCC) patients with cirrhosis or chronic hepatitis. METHODS: A total of 277 consecutive hepatectomies for HCC between 2005 and 2013 were analyzed retrospectively. Multivariate logistic regression analysis was used to develop a predictive model for PHLF. The sensitivity, specificity, and area under the receiver operating characteristic (AUROC) curve were evaluated. The Hosmer-Lemeshow goodness-of-fit test was used to assess the model calibration. The constructed model was internally validated by k-fold cross-validation (k=5). RESULTS: PHLF developed in 12.6% of hepatectomies. Multivariate analysis identified the following variables as predictors of PHLF: elevated preoperative serum bilirubin level, elevated preoperative international normalized ratio, and intraoperative packed red blood cell transfusion. The predictive model allowed discrimination between patients who developed PHLF and those who did not, with a sensitivity of 82.9%, specificity of 72.3%, and AUROC curve of 0.81 (95% CI, 0.74 to 0.89). The Hosmer-Lemeshow test indicated a good fit (P=0.545). The AUROC curve of the developed model was significantly greater than that of the model for end-stage liver disease (MELD) score (P=0.014), suggesting that the former model is better at predicting the PHLF than the latter one. CONCLUSIONS: The developed model could be useful for predicting the occurrence of PHLF in HCC patients with underlying liver disease.
PURPOSE: The aim of this study was to construct a prediction model for posthepatectomy liver failure (PHLF), as defined by the International Study Group of Liver Surgery, and evaluate its accuracy in hepatocellular carcinoma (HCC) patients with cirrhosis or chronic hepatitis. METHODS: A total of 277 consecutive hepatectomies for HCC between 2005 and 2013 were analyzed retrospectively. Multivariate logistic regression analysis was used to develop a predictive model for PHLF. The sensitivity, specificity, and area under the receiver operating characteristic (AUROC) curve were evaluated. The Hosmer-Lemeshow goodness-of-fit test was used to assess the model calibration. The constructed model was internally validated by k-fold cross-validation (k=5). RESULTS: PHLF developed in 12.6% of hepatectomies. Multivariate analysis identified the following variables as predictors of PHLF: elevated preoperative serum bilirubin level, elevated preoperative international normalized ratio, and intraoperative packed red blood cell transfusion. The predictive model allowed discrimination between patients who developed PHLF and those who did not, with a sensitivity of 82.9%, specificity of 72.3%, and AUROC curve of 0.81 (95% CI, 0.74 to 0.89). The Hosmer-Lemeshow test indicated a good fit (P=0.545). The AUROC curve of the developed model was significantly greater than that of the model for end-stage liver disease (MELD) score (P=0.014), suggesting that the former model is better at predicting the PHLF than the latter one. CONCLUSIONS: The developed model could be useful for predicting the occurrence of PHLF in HCC patients with underlying liver disease.
Authors: Nuh N Rahbari; O James Garden; Robert Padbury; Mark Brooke-Smith; Michael Crawford; Rene Adam; Moritz Koch; Masatoshi Makuuchi; Ronald P Dematteo; Christopher Christophi; Simon Banting; Val Usatoff; Masato Nagino; Guy Maddern; Thomas J Hugh; Jean-Nicolas Vauthey; Paul Greig; Myrddin Rees; Yukihiro Yokoyama; Sheung Tat Fan; Yuji Nimura; Joan Figueras; Lorenzo Capussotti; Markus W Büchler; Jürgen Weitz Journal: Surgery Date: 2011-01-14 Impact factor: 3.982
Authors: Jeffrey S Barton; Gordon M Riha; Jerome A Differding; Samantha J Underwood; Jodie L Curren; Brett C Sheppard; Rodney F Pommier; Susan L Orloff; Martin A Schreiber; Kevin G Billingsley Journal: HPB (Oxford) Date: 2013-01-29 Impact factor: 3.647
Authors: H S C Ribeiro; W L Costa; A L Diniz; A L Godoy; P Herman; R A Coudry; M D F S Begnami; C A L Mello; M J B Silva; C E Zurstrassen; F J F Coimbra Journal: Eur J Surg Oncol Date: 2013-01-22 Impact factor: 4.424
Authors: Margo Shoup; Mithat Gonen; Michael D'Angelica; William R Jarnagin; Ronald P DeMatteo; Lawrence H Schwartz; Scott Tuorto; Leslie H Blumgart; Yuman Fong Journal: J Gastrointest Surg Date: 2003 Mar-Apr Impact factor: 3.452
Authors: Malcolm H Squires; Gregory C Dann; Neha L Lad; Sarah B Fisher; Benjamin M Martin; David A Kooby; Juan M Sarmiento; Maria C Russell; Kenneth Cardona; Charles A Staley; Shishir K Maithel Journal: HPB (Oxford) Date: 2014-05-15 Impact factor: 3.647
Authors: Linda M Pak; Jayasree Chakraborty; Mithat Gonen; William C Chapman; Richard K G Do; Bas Groot Koerkamp; Kees Verhoef; Ser Yee Lee; Marco Massani; Eric P van der Stok; Amber L Simpson Journal: J Am Coll Surg Date: 2018-02-15 Impact factor: 6.113
Authors: Ken Min Chin; John Carson Allen; Jin Yao Teo; Juinn Huar Kam; Ek Khoon Tan; Yexin Koh; Kim Poh Brian Goh; Peng Chung Cheow; Prema Raj; Kah Hoe Pierce Chow; Yaw Fui Alexander Chung; London Lucien Ooi; Chung Yip Chan; Ser Yee Lee Journal: Ann Hepatobiliary Pancreat Surg Date: 2018-08-31
Authors: Emmanuel Gabriel; Jin Kim; Katherine T Ostapoff; Kristopher Attwood; Sergei Kurenov; Boris Kuvshinoff; Steven N Hochwald; Steven J Nurkin Journal: J Gastrointest Oncol Date: 2018-04